JOURNEY MEDICAL CORP (DERM) Institutional Shareholders

JOURNEY MEDICAL CORP (DERM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $75.51M in DERM holdings during the latest filing period.

Wasatch Advisors Lp is currently the largest disclosed institutional shareholder of DERM tracked by InsiderSet, reporting ownership valued at approximately $20.24M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $19.21M, representing an estimated loss of -5.08% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 73% of the total disclosed DERM value among the investors covered in this analysis. Major shareholders include Wasatch Advisors Lp, Tang Capital Management Llc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in JOURNEY MEDICAL CORP (DERM).

This page ranks the largest institutional DERM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

72

Total Reported Value

$75.51M

Largest Holder

Wasatch Advisors Lp

Largest Position

$20.24M

Insider Transactions (90d)

8

Latest Filing Quarter

Q2 2026

New Institutional Positions

107

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Wasatch Advisors Lp0.13%2,858,930$20,241,224$19,212,010-$1,029,214-5.08%
Tang Capital Management Llc0.52%1,610,000$11,398,800$10,819,200-$579,600-5.08%
Vanguard Capital Management Llc0.00%675,185$4,780,310$4,537,243-$243,067-5.08%
Punch & Associates Investment Management, Inc.0.19%536,000$3,794,880$3,601,920-$192,960-5.08%
Pale Fire Capital Se0.27%528,584$3,742,375$3,552,084-$190,291-5.08%
Opaleye Management Inc.0.22%350,000$2,478,000$2,352,000-$126,000-5.08%
Summit Financial, Llc0.03%346,748$2,454,976$2,330,147-$124,829-5.08%
Jane Street Group, Llc0.00%320,021$2,265,749$2,150,541-$115,208-5.08%
Diametric Capital, Lp0.22%295,663$2,093,294$1,986,855-$106,439-5.08%
Ikarian Capital, Llc0.29%251,436$1,780,168$1,689,650-$90,518-5.08%
Renaissance Technologies LLCJim Simons0.00%229,700$1,626,276$1,543,584-$82,692-5.08%
Geode Capital Management, Llc0.00%216,004$1,530,115$1,451,547-$78,568-5.13%
American Financial Group Inc0.45%180,000$1,274,400$1,209,600-$64,800-5.08%
Trexquant Investment Lp0.01%171,338$1,213,073$1,151,391-$61,682-5.08%
Marshall Wace, Llp0.00%139,843$990,087$939,745-$50,342-5.08%
J. Goldman & Co Lp0.03%137,584$974,095$924,564-$49,531-5.08%
Millennium Management Llc0.00%110,016$778,913$739,308-$39,605-5.08%
Blackrock, Inc.0.00%100,981$714,945$678,592-$36,353-5.08%
Xtx Topco Ltd0.01%100,923$714,535$678,203-$36,332-5.08%
Vanguard Fiduciary Trust Co0.00%94,729$670,681$636,579-$34,102-5.08%
Goldman Sachs Group Inc0.00%90,294$639,282$606,776-$32,506-5.08%
Ubs Group Ag0.00%83,514$591,279$561,214-$30,065-5.08%
Citadel Advisors Llc0.00%82,149$581,615$552,041-$29,574-5.08%
Pvg Asset Management Corp0.33%79,573$563,377$534,731-$28,646-5.08%
Integrated Wealth Concepts Llc0.00%78,928$558,809$530,396-$28,413-5.08%
Boothbay Fund Management, Llc0.01%67,442$477,489$453,210-$24,279-5.08%
State Street Corp0.00%65,978$467,124$443,372-$23,752-5.08%
Envestnet Asset Management Inc0.00%65,825$466,041$442,344-$23,697-5.08%
Walleye Capital Llc0.00%65,462$463,471$439,905-$23,566-5.08%
Geneos Wealth Management Inc.0.01%63,280$448,022$425,242-$22,780-5.08%
Arete Wealth Advisors, Llc0.01%51,792$366,687$348,042-$18,645-5.08%
Frec Markets, Inc.0.03%50,500$357,540$339,360-$18,180-5.08%
Bnp Paribas Financial Markets0.00%47,411$335,670$318,602-$17,068-5.08%
Squarepoint Ops Llc0.00%45,405$321,467$305,122-$16,345-5.08%
Morgan Stanley0.00%42,024$297,530$282,401-$15,129-5.08%
Bank Of America Corp0.00%41,907$296,701$281,615-$15,086-5.08%
Adar1 Capital Management, Llc0.01%39,517$279,780$265,554-$14,226-5.08%
State Of Wisconsin Investment Board0.00%35,904$254,200$241,275-$12,925-5.08%
Northern Trust Corp0.00%35,656$252,444$239,608-$12,836-5.08%
Salem Investment Counselors Inc0.01%29,200$206,736$196,224-$10,512-5.08%
Quadrature Capital Ltd0.00%28,841$204,194$193,812-$10,382-5.08%
Aqr Capital Management Llc0.00%24,877$176,129$167,173-$8,956-5.08%
Prelude Capital Management, Llc0.01%21,905$155,087$147,202-$7,885-5.08%
Susquehanna International Group, Llp0.00%20,001$141,607$134,407-$7,200-5.08%
Gladstone Institutional Advisory Llc0.00%20,000$141,600$134,400-$7,200-5.08%
Brevan Howard Capital Management Lp0.00%18,857$133,508$126,719-$6,789-5.09%
Invesco Ltd.0.00%16,679$118,087$112,083-$6,004-5.08%
Mariner, Llc0.00%13,348$94,505$89,699-$4,806-5.09%
Brighton Jones Llc0.00%12,702$89,931$85,357-$4,574-5.09%
Atria Investments, Inc0.00%11,941$84,542$80,244-$4,298-5.08%

Frequently asked questions about DERM

  • Who owns the most DERM stock?

    The largest holders of DERM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for JOURNEY MEDICAL CORP (DERM).

  • Is DERM widely held by superinvestors?

    Many widely followed stocks like DERM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DERM is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.